197 related articles for article (PubMed ID: 22207434)
1. Tumor budding in colorectal carcinomas.
Sert Bektaş S; Inan Mamak G; Cırış IM; Bozkurt KK; Kapucuoğlu N
Turk Patoloji Derg; 2012; 28(1):61-6. PubMed ID: 22207434
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
4. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Sakamoto A; Atomi Y
J Gastroenterol Hepatol; 2006 Jul; 21(7):1115-21. PubMed ID: 16824062
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
Wang LM; Kevans D; Mulcahy H; O'Sullivan J; Fennelly D; Hyland J; O'Donoghue D; Sheahan K
Am J Surg Pathol; 2009 Jan; 33(1):134-41. PubMed ID: 18971777
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
Park SY; Choe G; Lee HS; Jung SY; Park JG; Kim WH
Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
[TBL] [Abstract][Full Text] [Related]
7. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study.
Choi DH; Sohn DK; Chang HJ; Lim SB; Choi HS; Jeong SY
Dis Colon Rectum; 2009 Mar; 52(3):438-45. PubMed ID: 19333043
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
10. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma.
Saito S; Tsuno N; Nagawa H; Sunami E; Zhengxi J; Osada T; Kitayama J; Shibata Y; Tsuruo T; Muto T
Cancer; 2000 Jan; 88(1):42-9. PubMed ID: 10618604
[TBL] [Abstract][Full Text] [Related]
11. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type.
Sohn DK; Chang HJ; Park JW; Choi DH; Han KS; Hong CW; Jung KH; Kim DY; Lim SB; Choi HS; Jeong SY
J Clin Pathol; 2007 Aug; 60(8):912-5. PubMed ID: 16997919
[TBL] [Abstract][Full Text] [Related]
12. Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression.
Singson RP; Alsabeh R; Geller SA; Marchevsky A
Mod Pathol; 1999 May; 12(5):479-84. PubMed ID: 10349985
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
J Gastroenterol; 2003; 38(1):37-44. PubMed ID: 12560920
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
Akishima-Fukasawa Y; Nakanishi Y; Ino Y; Moriya Y; Kanai Y; Hirohashi S
Am J Clin Pathol; 2009 Aug; 132(2):202-10; quiz 307. PubMed ID: 19605814
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.
Ohtsuki K; Koyama F; Tamura T; Enomoto Y; Fujii H; Mukogawa T; Nakagawa T; Uchimoto K; Nakamura S; Nonomura A; Nakajima Y
Anticancer Res; 2008; 28(3B):1831-6. PubMed ID: 18630467
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
Fang W; Fan B; Xiong B
Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer.
Nakamura T; Mitomi H; Kikuchi S; Ohtani Y; Sato K
Hepatogastroenterology; 2005; 52(65):1432-5. PubMed ID: 16201089
[TBL] [Abstract][Full Text] [Related]
19. The association of stromal mast cell response and tumor cell differentiation in colorectal cancer.
Taweevisit M
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S69-73. PubMed ID: 17718271
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer.
Kaneko I; Tanaka S; Oka S; Kawamura T; Hiyama T; Ito M; Yoshihara M; Shimamoto F; Chayama K
Dis Colon Rectum; 2007 Jan; 50(1):13-21. PubMed ID: 17115337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
